Curant Health, a national outcomes-based patient support organization, today announced a partnership with BioCare Inc. companies’ BioCareSD, a leading distributor of life-saving therapies, and LogiCare3PL, BioCare’s 3PL solution. This synergy is meant to create an enhanced yet simplified single-source ecosystem, to support the complex rare disease patient and product needs.
BioCare utilizes over 40 years of specialty distribution experience and the latest technologies to ensure rare disease patients get the life-saving therapeutics they need, when they need them most. BioCare and Curant Health are addressing the significant unmet needs faced by the rare disease community daily by combining BioCareSD’s wide-reaching distribution network, LogiCare3PL’s third party logistic offerings, and Curant Health’s industry leading market access and patient support programs. In addition to shortening the supply chain, best-in-class performance benchmarks will be leveraged to ensure gold standard product and patient journey.
Also Read: Tampa General Hospital Again Named a Top Employer in Florida by Forbes
“This partnership is a major leap in prescription journey efficiency for rare disease patients,” said Jeff Beck, Chief Development Officer at BioCare. “Curant Health is the ideal company to help support the patient journey.”
“This partnership with BioCareSD and LogiCare3PL will ensure seamless transitions for the rare disease patient circumventing a multitude of gaps patients face in both getting on therapy and staying on therapy. Ultimately, the best indicator of success is the outcome of the patient. This partnership is designed to both measurably enhance the patient experience and meaningfully improve biopharma partner outcomes.” said Michell Butler, Senior Director of Clinical Services at Curant Health.
SOURCE: BusinessWire